Now FDA Approved

For adults with Ph+ CML in chronic phase previously treated with 2 or more TKIs, or those who have the T315I mutation

IMPORTANT SAFETY INFORMATION for SCEMBLIX® (asciminib) Tablets

Before taking SCEMBLIX, tell your doctor about all your medical conditions, including if you:

 

  • have a history of inflammation of your pancreas (pancreatitis)
  • have a history of heart problems or blood clots in your arteries and v...

See More
APPROVED USES for SCEMBLIX® (asciminib) Tablets

SCEMBLIX is a prescription medicine used to treat adults with:

 

  • Philadelphia chromosome–positive chronic myeloid leukemia (Ph+ CML...
See More

Switching to SCEMBLIX?

Learn why some patients who haven't responded to 2 or more TKIs are asking their doctor about SCEMBLIX® (asciminib) tablets.

LEARN MORE

Ph+ CML-CP With T315I Mutation?

Find out why your doctor may order a test to determine whether you have the T315I gene mutation and how SCEMBLIX may help.

LEARN MORE